3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Lymphedema
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Glioblastoma
1
Gallbladder Neoplasms
1
Endometrial Neoplasms
1
Encopresis
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Breast Cancer Female
1
Interventions
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Magnetic Resonance Spectroscopy
2
cabozantinib
1
X-Rays
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation Dose Hypofractionation
1
Positron Emission Tomography Computed Tomography
1
Platinum
1
Nivolumab
1
Metastasectomy
1
Laser Therapy
1
Laparoscopy
1
Ipilimumab
1
Indocyanine Green
1
Diffusion Magnetic Resonance Imaging
1
Cryosurgery
1
Cryoelectron Microscopy
1
Conversion to Open Surgery
1
Cisplatin
1
CTLA-4 Antigen
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphatic Metastasis
×
Radiation Dose Hypofractionation
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts